tirzepatide weight loss rate causes more than semaglutide Can Tirzepatide Help You Lose

Between 30 million and 50 million US adults could be taking a GLP-1 by 2034. In December 2024, 1.9 million prescriptions of GLP-1s to treat obesity (as opposed to diabetes, for example) were filled, nearly quadruple the number YoY, per IQVIA

While positive for consumers, it places significant financial pressure on an already brittle healthcare and Medicare ecosystem

100% Financing and Telehealth Available

Discover the UK clinical guidelines for safe dose re-titration, managing side effects, and maintaining long-term weight management success after treatment interruption.

Get started through a secure online assessment that only takes a few minutes to complete